Dual Release Carriers for Cochlear Delivery
Authors:
- 14 July 2015
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (1) , 94-100
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2Acta Biomaterialia, 2011
- Recent Progress in Nano‐biotechnology: Compartmentalized Micro‐ and Nanoparticles via Electrohydrodynamic Co‐jettingSmall, 2011
- A “tool box” for rational design of degradable controlled release formulationsJournal of Materials Chemistry, 2010
- Polysaccharide-Based Polyelectrolyte Multilayer Surface Coatings can Enhance Mesenchymal Stem Cell Response to Adsorbed Growth FactorsBiomacromolecules, 2010
- Guest Editorial: Accessible and Affordable Hearing Health Care for Adults with Mild to Moderate Hearing LossEar & Hearing, 2010
- Role of Particle Size in Phagocytosis of Polymeric MicrospheresPharmaceutical Research, 2008
- The major determinant of the heparin binding of glial cell-line-derived neurotrophic factor is near the N-terminus and is dispensable for receptor bindingBiochemical Journal, 2007
- Aspirin to Prevent Gentamicin-Induced Hearing LossNew England Journal of Medicine, 2006
- Cochlear implantation trauma and noise‐induced hearing loss: Apoptosis and therapeutic strategiesThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2006
- Glial cell line‐derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervationJournal of Comparative Neurology, 2002